Navigation Links
'Microfluidic palette' may paint clearer picture of biological processes
Date:7/29/2009

The masterpieces that spring from the talents of Rembrandt, Van Gogh and other artists often begin with the creation of a gradient of colors on a palette. In a similar manner, researchers at the National Institute of Standards and Technology (NIST) have created an innovative device called the "microfluidic palette" to produce multiple, steady-state chemical gradientsgradual changes in concentration across an areain a miniature chamber about the diameter of a pinhead. The tool can be used to study the complex biological mechanisms in cells responsible for cancer metastasis, wound healing, biofilm formation and other fluid-related processes.

The advantage of the NIST system, as described in a new paper,* is that the gradients are generated by diffusionthe gentle movement of matter from one point to another by random molecular motion. Microfluidic systems usually mix fluids more actively, by pumps and the circulation of currents. Diffusion gradients allow cells being studied to remain in the microchamber without the chance of their being swept away. Diffusion also permits chemical molecules to move in and out of the cells naturally and eliminates the risk of shear stresses, commonly produced by currents, which could cause the cells to rupture or behave abnormally.

The NIST microfluidic palette manages this with a clever plumbing trick. The key element of the palette is the microchamber, a small disk-shaped area only 1.5 millimeters (0.06 inch) across etched into the center of a glass wafer. Tiny holes at its circumferencethree in the prototype, but it could be moreallow various mixtures to flow into the chamber. Beneath the chamber, each access port connects to the long tail of a Y-shaped channel etched into a second layer. These channels deliver test chemicals to the chamber. Fluid flow in and out of the short arms of each Y at constant pressure assures a constant stream of fresh chemicals. Because the pressure in the chamber is balanced by filling it previously with a buffer solution, the test chemicals that migrate from the channels into the chamber do so almost entirely by diffusion. Therefore, as long as a constant flow of fluid is maintained through the Y's, the gradients in the chamber can be maintained virtually indefinitely.

To demonstrate how the microfluidic palette works, the NIST researchers inject dyes of the three primary colorsred, yellow and blueseparately into the three inlets of the system. For each dye, an independent gradient forms that remains constant as long as flow rate into the system does not change. Overlapping the three gradients results in a blend of dye concentrations in which the combination of colors at one location is distinctly different from any other location.

Similarly, if three separate drugs were injected into the palette where the microchamber contained a culture of cells, individual cells at different locations in the chamber would be exposed to different combinations of the drugs. In a single experiment, one could easily study the effects of a wide range of mixed drug concentrations on the same cell type.

Another potential application of the microfluidic palette is the study of chemotaxis, the movement of cells along a chemical gradient, a biological phenomenon that plays a role in the spread of cancer (metastasis), wound healing, infection and carbon cycling in the ocean.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology news :

1. Automated microfluidic device reduces time to screen small organisms for genetic studies
2. GEN reports on growing reliance on microfluidics technology
3. Nature leads the way for the next generation of paints, cosmetics and holograms
4. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
5. Synchrotron light unveils oil in ancient Buddhist paintings from Bamiyan
6. Scientists paint viruses to track their fate in the body
7. Beaded viruses and geology-inspired paintings show the art in science
8. Antarctic fossils paint a picture of a much warmer continent
9. Neural mapping paints a haphazard picture of odor receptors
10. Complex carbon picture clearer
11. Chicks to give scientists clearer picture of fetal development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Microfluidic palette' may paint clearer picture of biological processes
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: